Marko Zivin

Title: Marko Zivin - Innovator in Psychostimulant Addiction Treatment

Introduction

Marko Zivin is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the pharmaceutical industry, particularly in the treatment of psychostimulant addiction. His innovative approach addresses the pressing issue of cocaine addiction and its associated challenges.

Latest Patents

Marko Zivin holds a patent for a novel method for the treatment of psychostimulant addiction, specifically targeting cocaine addiction. The patent describes the use of 9,10-didehydro-N-methyl-N-(2-propyl)-6-methyl-8β-aminomethylergoline, also known as LEK-8829, in both its free base form and as pharmaceutically acceptable addition salts. This invention aims to reduce abstinence symptoms following cocaine withdrawal and suppress cravings associated with cocaine reinforcement. Additionally, the method extends to treating addictions related to amphetamines and their derivatives.

Career Highlights

Marko Zivin is associated with Lek Pharmaceuticals D.d., a prominent company in the pharmaceutical sector. His work focuses on developing effective treatments for addiction, showcasing his commitment to improving public health through innovative solutions.

Collaborations

Marko has collaborated with notable colleagues, including Igor Krisch and Natasa Milivojevic, to advance research and development in addiction treatment.

Conclusion

Marko Zivin's contributions to the field of psychostimulant addiction treatment highlight his innovative spirit and dedication to addressing critical health issues. His patent represents a significant step forward in the pharmaceutical industry, offering hope for those struggling with addiction.